Free Access
Med Sci (Paris)
Volume 18, Number 6-7, Juin–Juillet 2002
Page(s) 737 - 743
Section M/S Revues : Articles de Synthèse
Published online 15 June 2002
  1. Lobo A, Launer LJ, Fratiglioni L, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 2000; 54 (suppl 5) : S4–9. [Google Scholar]
  2. American Psychiatric Association. Manuel diagnostique et statistique des troubles mentaux. DSM-III-R. Paris : Masson, 1989. [Google Scholar]
  3. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of health and human services task force on Alzheimer’s disease. Neurology 1984; 34 : 939–44. [Google Scholar]
  4. Fratiglioni L, Launer LJ, Andersen K, et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 2000; 54 (suppl 5) : S10–5. [Google Scholar]
  5. Letenneur L, Commenges D, Dartigues JF, Barberger-Gateau P. Incidence of dementia and Alzheimer’s disease in elderly community residents of south-western France. Int J Epidemiol 1994; 23 : 1256–61. [Google Scholar]
  6. Letenneur L, Gilleron V, Commenges D, Helmer C, Orgogozo JM, Dartigues JF. Are sex and educational level independent predictors of dementia and Alzheimer’s disease? Incidence data from the PAQUID project. J Neurol Neurosurg Psychiatr 1999; 66 : 177–83. [Google Scholar]
  7. Edland SD, Rocca W, Petersen RC, Cha RH, Kokmen E. The incidence of Alzheimer’s disease does not vary by gender in Rochester, MN. Neurobiol Aging 2000; 21 : S203. [Google Scholar]
  8. Breitner JCS, Folstein MF, Murphy EA. Familial agregation in Alzheimer dementia. J Psychiatr Res 1986; 20 : 31–43. [Google Scholar]
  9. Launer LJ, Andersen K, Dewey ME, et al. Rates and risk factors for dementia and Alzheimer’s disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 1999; 52 : 78–84. [Google Scholar]
  10. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer Disease. Meta analysis consortium. JAMA 1997; 278 : 1349–58. [Google Scholar]
  11. Stern RG, Mohs RC, Davidson M, et al. A longitudinal study of Alzheimer’s disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry 1994; 151 : 390–6. [Google Scholar]
  12. Graves AB, Mortimer JA, Bowen JD, et al. Head circumference and incident Alzheimer’s disease -Modification by apolipoprotein E. Neurology 2001; 57 : 1453–60. [Google Scholar]
  13. Schofield P, Logroscino G, Andrews H, Albert S, Stern Y. An association between head circonference and Alzheimer’disease in a population-based study of aging and dementia. Neurology 1997; 49 : 30–7. [Google Scholar]
  14. Fabrigoule C, Letenneur L, Dartigues JF, Zarrouk M, Commenges D, Barberger-Gateau P. Social and leisure activities and risk of dementia: a prospective longitudinal study. J Am Geriatr Soc 1995; 43 : 485–90. [Google Scholar]
  15. Helmer C, Damon D, Letenneur L, et al. Marital status and risk of Alzheimer’s disease : a French population-based cohort study. Neurology 1999; 53 : 1953–8. [Google Scholar]
  16. Fratiglioni L, Wang HX, Ericsson K, Maytan M, Winblad B. Influence of social network on occurrence of dementia: a community-based longitudinal study. Lancet 2000; 355 : 1315–9. [Google Scholar]
  17. Mayeux R, Ottman R, Tang M, et al. Genetic susceptibility and head injury as risk factors for Alzheimer’s disease among community-dwelling elderly persons and their first-degree relatives. Ann Neurol 1993; 33 : 494–501. [Google Scholar]
  18. Li G, Shen Y, Li Y, Chen C, Zhau Y, Silverman J. A case-control study of Alzheimer’s disease in China. Neurology 1992; 42 : 1481–8. [Google Scholar]
  19. Mehta K, Ott A, Kalmijn S, et al. Head trauma and risk of dementia and Alzheimer’s disease: the Rotterdam Study. Neurology 2000; 53 : 1959–62. [Google Scholar]
  20. Jorm AF. Is depression a risk factor for dementia or cognitive decline : a review. Gerontology 2000; 46 : 219–27. [Google Scholar]
  21. Orgogozo JM, Dartigues JF, Lafont S, et al. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol 1997; 153 : 185–92. [Google Scholar]
  22. Lemeshow S, Letenneur L, Dartigues JF, Lafont S, Orgogozo JM, Commenges D. Illustration of analysis taking into account complex survey considerations: the association between wine consumption and dementia in the Paquid study. Am J Epidemiol 1998; 148 : 298–306. [Google Scholar]
  23. Ruitenberg A, Swieten JC, Hofman A, Breteler MMB. Alcohol consumption and risk of dementia: results from the Rotterdam study. Neurobiol Aging 2000; 21 : 1129. [Google Scholar]
  24. Kalmijn S, Launer LJ, Ott A, Wittemen JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann Neurol 1997; 42 : 776–82. [Google Scholar]
  25. Martyn CN, Barker JP, Osmond C, Harris EC, Edwarson JA, Lacey RF. Geographical relation between Alzheimer’s disease and aluminium in drinking water. Lancet 1989; 14 : 59–62. [Google Scholar]
  26. Martyn C, Coggon D, Lacey R. Aluminium concentrations in drinking water and risk of Alzheimer’s disease. Epidemiology 1997; 8 : 281–6. [Google Scholar]
  27. Rondeau V, Commenges D, Jacqmin-Gadda H, Dartigues JF. Relation between aluminum concentrations in drinking water and Alzheimer’s disease: An 8-year followup study. Am J Epidemiol 2000; 152 : 59–66. [Google Scholar]
  28. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer’s disease in women. Am J Epidemiol 1994; 140 : 256–61. [Google Scholar]
  29. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer’s disease: the Baltimore longitudinal study of aging. Neurology 1997; 48 : 1517–21. [Google Scholar]
  30. Breitner JCS, Zandi PP. Do nonsteroidal antiinflammatory drugs reduce the risk of Alzheimer’s disease? N Engl J Med 2001; 345 : 1567–8. [Google Scholar]
  31. Intveld BA, Ruitenberg A, Hofman A, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer’s disease. N Engl J Med 2001; 345 : 1515–21. [Google Scholar]
  32. Hofman A, Ott A, Breteler MMB, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam study. Lancet 1997; 349 : 151–4. [Google Scholar]
  33. Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352 : 1347–51. [Google Scholar]
  34. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologica 1996; 39 : 1392–7. [Google Scholar]
  35. Vanduijn C, Stijnen T, Hofman A. Risk factors for Alzheimer’s disease : overview of the Eurodem collaborative reanalysis of case-control studies. Int J Epidemiol 1991; 20 (suppl 2) : S4–12. [Google Scholar]
  36. Merchant C, Tang M, Albert S, Manly J, Stern Y, Mayeux R .The influence of smoking on the risk of Alzheimer’s disease. Neurology 1999; 52 : 1408–12. [Google Scholar]
  37. Bonarek M, Barberger-Gateau P, Letenneur L, et al. Relationships between cholesterol, apolipoprotein E polymorphism and dementia: a cross-sectional analysis from the Paquid study. Neuroepidemiology 2000; 19 : 141–8. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.